The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse

Thrombosis and Haemostasis

Volumn 109, Issue 6, 2013, Pages 1158-1169

  Diaz, Jose A ^a   Alvarado, Christine M ^a   Wrobleski, Shirley K ^a   Slack, Dallas W ^a   Hawley, Angela E ^a   Farris, Diana M ^a   Henke, Peter K ^a   Wakefield, Thomas W ^a   Myers, Daniel D ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Animal model; EIM; Electrolytic; Thrombus resolution; Venous thrombosis

Indexed keywords

IOHEXOL; PADGEM PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD FLOW; BLOOD VESSEL WALL; CONTROLLED STUDY; ECHOGRAPHY; ELECTRIC CURRENT; ELECTROLYTIC INFERIOR VENA CAVA MODEL; INFERIOR CAVA VEIN OBSTRUCTION; INFLAMMATION; MALE; MODEL; MORPHOMETRICS; MOUSE; NONHUMAN; PHLEBOGRAPHY; PRIORITY JOURNAL; SUTURE NEEDLE; SUTURE WIRE; THROMBUS; VASCULAR FIBROSIS; VEIN THROMBOSIS; VEIN WALL;

EID: 84878648604     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-09-0711     Document Type: Article

References (29)

1. Burnand KG, Gaffney PJ, McGuinness CL, et al. The role of the monocyte in the generation and dissolution of arterial and venous thrombi. Cardiovasc Surg 1998; 6: 119-125.
2. Cooley BC, Szema L, Chen CY, et al. A murine model of deep vein thrombosis: characterisation and validation in transgenic mice. Thromb Haemost. 2005 Sep;94(3):498-503.
3. Henke PK, Varga A, De S, Deatrick CB, et al. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arte-rioscler Thromb Vasc Biol 2004; 24: 1130-1137.
4. Myers DD, Farris D, Hawley A, et al. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res 2002; 108: 212-221.
5. Myers DD, Hawley AE, Farris DM, et al. P-selectin and leukocyte micropar-ticles are associated with venous thrombogenesis. J Vasc Surg. 2003; 38: 1075-1089.
6. Myers DD, Henke PK, Wakefield T W. Coagulation biology. In: Surgical Research. San Diego: Academic Press; 2001. pp. 989-1000.
7. Singh I, Smith A, Vanzieleghem B, et al. Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model. Blood 2002; 99: 3235-3240.
8. Patterson KA, Zhang X, Wrobleski SK, et al. Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects. Thromb Res 2012; epub ahead of print.
9. Wojcik BM, Wrobleski SK, Hawley AE, Wakefield T W, Myers DD, Jr., Diaz JA. Interleukin-6: a potential target for post-thrombotic syndrome. Ann Vasc Surg 2011; 25: 229-239.
10. Day SM, Reeve JL, Myers DD, et al. Murine thrombosis models. Thromb Hae-most 2004; 92: 486-494.
11. Diaz JA, Ballard-Lipka NE, Farris DM, et al. Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis. J Vasc Surg 2012; 55: 815-822.
12. Wrobleski SK, Farris DM, Diaz JA, et al. Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis. J Vis Exp 2011; Epub ahead of print.
13. Diaz JA, Obi AT, Myers DD, et al. Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol 2012; 32: 556-562.
14. Diaz JA, Hawley AE, Alvarado CM, et al. Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model. Thromb Haemost 2010; 104: 366-375.
15. Diaz JA, Wrobleski SK, Hawley AE, et al. Electrolytic inferior vena cava model (EIM) of venous thrombosis. J Vis Exp 2011; Epub ahead of print.
16. Romson JL, Haack DW, Lucchesi BR. Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents. Thromb Res 1980; 17: 841-853.
17. Jackson C V, Mickelson JK, Pope TK, et al. O2 free radical-mediated myocardial and vascular dysfunction. Am J Physiol 1986; 251: H1225-1231.
18. Council NR. Guide for the Care and Use of Laboratory Animals. 1996: pp. 1-125.
19. Rectenwald JE, Myers DD, Jr., Hawley AE, et al. D-dimer, P-selectin, and micro-particles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost 2005; 94: 1312-1317.
20. Ramacciotti E, Blackburn S, Hawley AE, et al. Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb He-most 2011; 17: 425-431.
21. Ay C, Kaider A, Koder S, Husslein P, et al. Association of elevated soluble P-se-lectin levels with fetal loss in women with a history of venous thromboembol-ism. Thromb Res 2012; 129: 725-728.
22. Ay C, Simanek R, Vormittag R, et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 2008; 112: 2703-2708.
23. Culmer DL, Diaz JA, Hawley AE, et al. Circulating and vein wall P-selectin promote venous thrombogenesis during aging in a rodent model. Thromb Res 2013; 131: 42-48.
24. Stewart GJ, Ritchie WG, Lynch PR. Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol 1974; 74: 507-532.
25. Myers DD, Rectenwald JE, Bedard P W, et al. Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg 2005; 42: 329-336.
26. Myers DD, Henke PK, Bedard P W, et al. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg 2006; 44: 625-632.
27. Henke PK, Mitsuya M, Luke CE, et al. Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution. Arterioscler Thromb Vasc Biol 2011; 31: 43-49.
28. Diaz JA OA, Myers DD, Wrobleski, SK, et al. Re:Thoughts on murine models of deep vein thrombosis - eLetter - Original article: Critical Review of Mouse Models of Venous Thrombosis. Atheroscl Thromb Vasc Biol 2012; 32: 556-562.
29. Institute for Laboratory Animal Research (U.S.). Committee on New and Emerging Models in Biomedical and Behavioral Research. Biomedical models and resources: current needs and future opportunities. Washington, D.C.: National Academy Press; 1998.